These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 8990388)

  • 1. T cell independence of macrophage and natural killer cell infiltration, cytokine production, and endothelial activation during delayed xenograft rejection.
    Candinas D; Belliveau S; Koyamada N; Miyatake T; Hechenleitner P; Mark W; Bach FH; Hancock WW
    Transplantation; 1996 Dec; 62(12):1920-7. PubMed ID: 8990388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of leflunomide and deoxyspergualin in the guinea pig-->rat cardiac model of delayed xenograft rejection: suppression of B cell and C-C chemokine responses but not induction of macrophage lectin.
    Hancock WW; Miyatake T; Koyamada N; Kut JP; Soares M; Russell ME; Bach FH; Sayegh MH
    Transplantation; 1997 Sep; 64(5):696-704. PubMed ID: 9311705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
    Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
    Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolongation of cardiac xenograft survival by depletion of complement.
    Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
    Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection.
    Blakely ML; Van der Werf WJ; Berndt MC; Dalmasso AP; Bach FH; Hancock WW
    Transplantation; 1994 Nov; 58(10):1059-66. PubMed ID: 7974711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of repetitive high-dose treatment with soluble complement receptor type 1 and cobra venom factor on discordant xenograft survival.
    Candinas D; Lesnikoski BA; Robson SC; Miyatake T; Scesney SM; Marsh HC; Ryan US; Dalmasso AP; Hancock WW; Bach FH
    Transplantation; 1996 Aug; 62(3):336-42. PubMed ID: 8779679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and pathology of delayed xenograft rejection in pig-to-rhesus monkey cardiac transplantation.
    Chen D; Cao R; Guo H; Chen G; Wang X; Shen S; Chen S
    Transplant Proc; 2004 Oct; 36(8):2480-2. PubMed ID: 15561288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beyond hyperacute rejection. Accelerated rejection in a discordant xenograft model by adoptive transfer of specific cell subsets.
    Fryer JP; Leventhal JR; Dalmasso AP; Chen S; Simone PA; Goswitz JJ; Reinsmoen NL; Matas AJ
    Transplantation; 1995 Jan; 59(2):171-6. PubMed ID: 7839436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet integrin GPIIbIIIa prolongs survival of discordant cardiac xenografts.
    Candinas D; Lesnikoski BA; Hancock WW; Otsu I; Koyamada N; Dalmasso AP; Robson SC; Bach FH
    Transplantation; 1996 Jul; 62(1):1-5. PubMed ID: 8693522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Natural killer cell- and macrophage mediated discordant guinea pig-->rat xenograft rejection in the absence of complement, xenoantibody and T cell immunity.
    Xia G; Ji P; Rutgeerts O; Waer M
    Transplantation; 2000 Jul; 70(1):86-93. PubMed ID: 10919580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy.
    Kobayashi T; Taniguchi S; Neethling FA; Rose AG; Hancock WW; Ye Y; Niekrasz M; Kosanke S; Wright LJ; White DJ; Cooper DK
    Transplantation; 1997 Nov; 64(9):1255-61. PubMed ID: 9371665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival of hamster hearts in presensitized rats.
    Lin Y; Soares MP; Sato K; Csizmadia E; Robson SC; Smith N; Bach FH
    J Immunol; 2000 May; 164(9):4883-92. PubMed ID: 10779798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abrogation by rapamycin of accelerated rejection in sensitized rats by inhibition of alloantibody responses and selective suppression of intragraft mononuclear and endothelial cell activation, cytokine production, and cell adhesion.
    Schmidbauer G; Hancock WW; Wasowska B; Badger AM; Kupiec-Weglinski JW
    Transplantation; 1994 Mar; 57(6):933-41. PubMed ID: 8154043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment with a short course of LF 15-0195 and continuous cyclosporin A attenuates acute xenograft rejection in a rat-to-mouse cardiac transplantation model.
    Wang H; Hosiawa KA; Garcia B; Shum JB; Dutartre P; Kelvin DJ; Zhong R
    Xenotransplantation; 2003 Jul; 10(4):325-36. PubMed ID: 12795681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model.
    Candinas D; Mark W; Kaever V; Miyatake T; Koyamada N; Hechenleitner P; Hancock WW
    Transplantation; 1996 Dec; 62(12):1855-60. PubMed ID: 8990376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged discordant xenograft survival and delayed xenograft rejection in a pig-to-baboon orthotopic cardiac xenograft model.
    Xu H; Gundry SR; Hancock WW; Matsumiya G; Zuppan CW; Morimoto T; Slater J; Bailey LL
    J Thorac Cardiovasc Surg; 1998 Jun; 115(6):1342-9. PubMed ID: 9628677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral and cellular immunopathology of hepatic and cardiac hamster-into-rat xenograft rejection. Marked stimulation of IgM++bright/IgD+dull splenic B cells.
    Langer A; Valdivia LA; Murase N; Woo J; Celli S; Fung JJ; Starzl TE; Demetris AJ
    Am J Pathol; 1993 Jul; 143(1):85-98. PubMed ID: 7686346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of antibody synthesis and complement activation in concordant xenograft retransplantation.
    Gannedahl G; Karlsson-Parra A; Wallgren A; Roos-Engstrand E; Nilsson B; Tötterman TH; Tufveson G
    Transplantation; 1994 Aug; 58(3):337-44. PubMed ID: 8053058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclosporine and anti-interleukin 2 receptor monoclonal antibody therapy suppress accelerated rejection of rat cardiac allografts through different effector mechanisms.
    Hancock WW; DiStefano R; Braun P; Schweizer RT; Tilney NL; Kupiec-Weglinski JW
    Transplantation; 1990 Feb; 49(2):416-21. PubMed ID: 2106180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of delayed xenograft rejection by specific depletion of elicited antibodies of the IgM isotype.
    Sato K; Takigami K; Miyatake T; Czismadia E; Latinne D; Bazin H; Bach FH; Soares MP
    Transplantation; 1999 Sep; 68(6):844-54. PubMed ID: 10515386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.